Critical role and regulation of transcription factor foxm1 in human gastric cancer angiogenesis and progression

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3501-3509

  Li, Qiang ^a   Zhang, Nu ^a   Jia, Zhiliang ^a   Le, Xiangdong ^a   Dai, Bingbing ^a   Wei, Daoyan ^a   Huang, Suyun ^a   Tan, Dongfeng ^a   Xie, Keping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NECK; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; STOMACH CANCER; STOMACH MUCOSA; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR PROMOTION; TUMOR VASCULARIZATION;

ANIMALS; CELL GROWTH PROCESSES; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65949124894     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3045     Document Type: Article

References (50)

1. Jemal A, Siegel K, Ward E. et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008; 58: 71-96
2. Parkin DM, Bray H Eerlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
3. Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin. K Am 2008; 17: 323-40, viii.
4. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7: 61-77. (Pubitemid 38899656)
5. Whisenant J, Bergsland E. Anti-angiogenic strategies in gastrointestinal malignancies. Curr Treat Options Oncol 2005: 6: 411-21. (Pubitemid 41684221)
6. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-15. (Pubitemid 36936845)
7. Chan AO, Luk JM, Hui WM, Lam SK. Molecular biology of gastric carcinoma: from laboratory to bedside, J. Gastroenterol Hepatol 1999; 14; 1150-60. (Pubitemid 30032952)
8. Yao JC, Wang L, Wei D. et al. Association between expression of transcription factor Spl and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin. Cancer Res 2004: 10: 4109-17. (Pubitemid 38812490)
9. Jiang Y, Wang L, Gong W. et al. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Spl and regional lymph node metastasis of human gastric cancer. Clin. Exp Metastasis 2004; 21: 755-64.
10. Chen CM, Cheng YM, Lin MT, Hsieh EJ, Lee PR Chang KJ. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer, Ann Surg 2002; 235: 512-8 (Pubitemid 34258350)
11. Sanz-Ortega J, Steinberg SM, Moro E. et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol 2000; 15: 455-62. (Pubitemid 30218839)
12. Wang L, Wei D, Huang S. et al. Transcription factor Spl expression is a significant predictor ot survival in human gastric cancer, Clin. Cancer Res 2003; 9: 6371-80 (Pubitemid 38031822)
13. Gong W, Wang L, Yao JC. et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer, Clin. Cancer Res 2005; 11: 1386-93. (Pubitemid 40315217)
14. Gartel AL. EoxM1 inhibitors as potential anticancer drugs. Expert Opin Ther. Targets 2008; 12: 663-5.
15. Myatt SS, Lam EW, Targeting FOXM1, Nat. Rev. Cancer 2008; 8: 242.
16. Ye H, Kelly TF, Samadani U. et al, Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell Biol. 1997; 17: 1626-41. (Pubitemid 27097392)
17. Korver W, Roose J, Heinen K. et al. The human TRIDENT/HEH-11/FKHL16 gene: structure, localization, and promoter characterization. Genomics 1997; 46: 435-42. (Pubitemid 28063292)
18. Yao KM, Sha M, Lu Z, Wong GG. Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J. Biol. Chem 1997; 272: 19827-36. (Pubitemid 27340077)
19. Korver W, Roose J, Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 1997: 25: 1715-9. (Pubitemid 27303351)
20. Westendorf JM, Rao PN, Gerace L, Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope, Proc. Natl. Acad. Sci. U S A 1994; 91: 714-8. (Pubitemid 24041472)
21. Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH, Premature expression of the winged helix transcription factor HFH-UB in regenerating mouse liver accelerates hepatocyte entry into S phase, Mol. Cell Biol. 1999; 19: 8570-80. (Pubitemid 30414050)
22. Luscher-Firzlaff JM, Westendorf JM, Zwicker J. et al. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation, Oncogene 81999; 18: 5620-30. (Pubitemid 29497596)
23. Wang X, Kiyokawa H, Dennewitz MB, Costa RH, The Forkhead Box rnlb transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration, Proc. Natl. Acad. Sci. U S A 2002; 99: 16881-6. (Pubitemid 36034067)
24. Laoukili J, Kooistra MR, Bras A. et al. FoxMl is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005: 7: 126-36. (Pubitemid 40268127)
25. Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 2005: 65: 5181-9. (Pubitemid 40827327)
26. Leung TW, Lin SS, Tsang AC. et al. Over-expression of EoxMl stimulates cyclin BI expression. EEBS Lett 2001; 507: 59-66. (Pubitemid 33000299)
27. Park HI, Wang Z, Costa RH, Tyner A, Lau LE, Raychaudhuri P. An K-terminal inhibitory domain modulates activity of FoxMl during cell cycle. Oncogene 2008; 27: 1696-704.
28. Park HJ, Costa RH, Lau LF, Tyner AL, Raychaudhuri P. Anaphase-promoting complex/cyclosome-CDHlmediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase, Mol. Cell Biol. 2008; 28: 5162-71.
29. Wang X, Krupczak-Hollis K, Tan Y, Dennewitz MB, Adami GR, Costa RH. Increased hepatic Forkhead Box M1B (EoxMlB) levels in old-aged mice stimulated liver regeneration through diminished p27Kipl protein levels and increased Cdc25B expression. J. Biol. Chem 2002; 277: 44310-6 (Pubitemid 36157865)
30. Teh MT, Wong ST, Keill GW, Ghali LR, Philpott MP, Quinn AG. EOXM1 is a downstream target of Glil in basal cell carcinomas. Cancer Res 2002; 62: 4773-80.
31. Kalinichenko W, Gusarova GA, Kim IM. et al, Foxfl haploinsufficiency reduces Notch~2 signaling during mouse lung development. Am J. Physiol Lung Cell Mol. Physiol 2004; 286: L521-30 (Pubitemid 38233623)
32. Lee JS, Chu IS, Heo J. et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004; 40: 667-76. (Pubitemid 39265589)
33. Kim IM, Ackerson T, Ramakrishna S. et al. The Forkhead Box ml transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006: 66: 2153-61. (Pubitemid 43294925)
34. Obama K, Ura K, Li M. et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005; 41: 1339-48. (Pubitemid 40770287)
35. Dai B, Kang SH, Gong W. et al. Aberrant EoxMlB expression increases matrix met al.loproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 2007; 26: 6212-9. (Pubitemid 47414378)
36. Liu M, Dai B, Kang SH. et al, FoxMlB is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 2006; 66: 3593-602.
37. Yoshida Y, Wang IC, Yoder HM, Davidson NO, Costa RH, The forkhead box Ml transcription factor contributes to the development and growth of mouse colorectal cancer, Gastroenterology 2007; 132: 1420-31 (Pubitemid 46627572)
38. Kalin TV, Wang IC, Ackerson TJ. et al. Increased levels of the FoxMl transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006; 66: 1712-20. (Pubitemid 43259956)
39. Bektas N, Haaf A, Veeck J. et al. Tight correlation between expression of the Forkhead transcription factor F0XM1 and HER2 in human breast cancer, BMC cancer 2008; 8: 42.
40. Chan D, Yu S, Chiu P. et al. Over-expression of F0XM1 transcription factor is associated with cervical cancer progression and pathogenesis. J. Pathol 2008: 215: 245-52
41. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004; 6: 744-50. (Pubitemid 40041492)
42. Kanai M, Wei D, Li Q. et al. Loss of Kruppel-like factor 4 expression contributes to Spl overexpression and human gastric cancer development and progression. Clin. Cancer Res 2006; 12: 6395-402.
43. Major ML, Lepe R, Costa RH. Forkhead Box M1B transcriptional activity requires binding ot Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol. Cell Biol. 2004; 24: 2649-61. (Pubitemid 38381258)
44. Abid MR, Shin SC, Otu HH. et al. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J. Biol. Chem 2006; 281: 35544-53. (Pubitemid 46043252)
45. Puruyama T, Kitayama K, Shimoda Y. et al. Abnormal angiogenesis in Foxol (Fkhr) -deficient mice, J. Biol. Chem 2004; 279: 34741-9. (Pubitemid 39318105)
46. Gupta S, Joshi K, Wig JD, Arora SK. Intratumoral FOXP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis. Acta Oncol 2007; 46: 792-7. (Pubitemid 47123764)
47. Banham AH, Boddy J, Launchbury R. et al. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate 2007; 67: 1091-8. (Pubitemid 46983338)
48. TrembleyJH, Ebbert JO, Kren BT, Steer CJ. Differential regulation of cyclin Bl RNA and protein expression during hepatocyte growth in vivo. Cell Growth Differ 1996; 7: 903-16. (Pubitemid 26360730)
49. Kalinichenko W, Major ML, Wang X. et al. Foxmlb transcription factor is essential for development ot hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004; 18: 830-50. (Pubitemid 38480894)
50. Gusarova GA, Wang IC, Major ML. et al. A cellpenetrating ARF peptide inhibitor of FoxMl in mouse hepatocellular carcinoma treatment. J. Clin. Invest 2007; 117: 99-111. (Pubitemid 46048457)